Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 147 for kidney and hypertension

Edit search filters
  1. A Study of Heart and Kidney Protection with Empagliflozin

    Jacksonville, FL

  2. A Study of the Long-Term Safety, Tolerability, and Effectiveness of Tesevatinib for Patients Completing 24 Months of Treatment for Autosomal Dominant Polycystic Kidney Disease

    Rochester, MN

  3. Stem Cell Therapy for Chronic Kidney Disease

    Jacksonville, FL

  4. Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

    Rochester, MN

  5. Combination Chemotherapy and Surgery in Treating Young Patients with Wilms Tumor

    Rochester, MN

  6. A Study to Evaluate the Long Term Safety of Titrated Immediate-Release Tolvaptan in Subjects with Autosomal Dominant Polycystic Kidney Disease

    Rochester, MN

  7. A Study to Evaluate Patient Outcomes in Care Transition of Acute Kidney Injury (AKI) Survivors

    Rochester, MN

  8. Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

    Jacksonville, FL

  9. Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients

    Rochester, MN

  10. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

    Rochester, MN, Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer